Silhouette

Michelle M. Butler

Microbiotix, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Aminospectinomycin antibacterials for the treatment of antibiotic-resistant gonorrhea and other ...
Microbiotix, Inc.
Principal Investigator
HHS 1 $297K 08/18/17 07/31/18
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
Microbiotix, Inc.
Principal Investigator
HHS 2 $982K 06/01/16 05/31/17
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
Microbiotix, Inc.
Principal Investigator
HHS 2 $690K 01/01/16 12/31/16
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
Microbiotix, Inc.
Principal Investigator
HHS 2 $988K 06/01/15 05/31/16
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
Microbiotix, Inc.
Principal Investigator
HHS 2 $644K 01/01/15 12/31/15
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
Microbiotix, Inc.
Principal Investigator
HHS 2 $1000K 06/15/14 05/31/15
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
Microbiotix, Inc.
Principal Investigator
HHS 1 $296K 09/01/13 08/31/14
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
Microbiotix, Inc.
Principal Investigator
HHS 1 $291K 03/01/13 02/28/14
Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drugs
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 09/21/12 08/31/13
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
Microbiotix, Inc.
Principal Investigator
HHS 1 $294K 03/01/12 02/28/13
Novel Antibacterials Targeting Gram-negative Nonfermenters
Microbiotix, Inc.
Principal Investigator
HHS 1 $261K 03/01/10 02/28/12
Novel Antibacterials Targeting Gram-negative Nonfermenters
Microbiotix, Inc.
Principal Investigator
HHS 1 $260K 03/15/09 02/28/10
Bacterial DnaA Initiator Protein: A Target for Novel Antibiotics
Microbiotix, Inc.
Principal Investigator
HHS 1 $294K 02/01/08 01/31/10
Development of Inhibitors of Mycobacterium Tuberculosis DNA Replication
Microbiotix, Inc.
Principal Investigator
HHS 1 $261K 09/01/07 08/31/09
Development of Inhibitors of Mycobacterium Tuberculosis DNA Replication
Microbiotix, Inc.
Principal Investigator
HHS 1 $289K 09/06/06 08/31/07
Bacterial DNA Polymerases: Target for Novel Antibiotics
Microbiotix, Inc.
Principal Investigator
HHS 2 $690K 07/01/05 06/30/07
Development of Screens for Bacillus Anthracis Targets
Microbiotix, Inc.
Principal Investigator
HHS 1 $387K 01/01/05 12/31/06
Bacterial DNA Polymerases: Target for Novel Antibiotics
Microbiotix, Inc.
Principal Investigator
HHS 2 $762K 07/01/04 06/30/05
A Novel Therapy for Respiratory Syncytial Virus
Microbiotix, Inc.
Principal Investigator
HHS 1 $399K 02/01/03 01/31/04
Bacterial DNA Polymerases: Targets for Novel Antibiotic
Microbiotix, Inc.
Principal Investigator
HHS 1 $224K 09/30/01 03/31/02